mRNA vaccine effectiveness against asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection over seven months

Infect Control Hosp Epidemiol. 2022 Mar;43(3):393-395. doi: 10.1017/ice.2021.399. Epub 2021 Sep 6.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • RNA, Messenger
  • SARS-CoV-2*
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • RNA, Messenger
  • Vaccines, Synthetic
  • mRNA Vaccines